Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Treatment of Post-Stroke Depression.

Starkstein SE, Hayhow BD.

Curr Treat Options Neurol. 2019 Jun 25;21(7):31. doi: 10.1007/s11940-019-0570-5. Review.

PMID:
31236751
2.

Anosognosia Is Associated With Greater Caregiver Burden and Poorer Executive Function in Huntington Disease.

Wibawa P, Zombor R, Dragovic M, Hayhow B, Lee J, Panegyres PK, Rock D, Starkstein SE.

J Geriatr Psychiatry Neurol. 2019 Jun 18:891988719856697. doi: 10.1177/0891988719856697. [Epub ahead of print]

PMID:
31213121
3.

Clinical risk factors for depressive syndrome in Type 2 diabetes: the Fremantle Diabetes Study.

Bruce DG, Davis WA, Starkstein SE, Davis TME.

Diabet Med. 2018 Jul;35(7):903-910. doi: 10.1111/dme.13631. Epub 2018 May 2.

PMID:
29608787
4.

Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus.

Milne NT, Bucks RS, Davis WA, Davis TME, Pierson R, Starkstein SE, Bruce DG.

Brain Behav. 2017 Dec 22;8(1):e00741. doi: 10.1002/brb3.741. eCollection 2018 Jan.

5.

The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.

Davis WA, Bruce DG, Dragovic M, Davis TME, Starkstein SE.

PLoS One. 2018 Mar 15;13(3):e0194417. doi: 10.1371/journal.pone.0194417. eCollection 2018.

6.

The neuroimaging basis of apathy: Empirical findings and conceptual challenges.

Starkstein SE, Brockman S.

Neuropsychologia. 2018 Sep;118(Pt B):48-53. doi: 10.1016/j.neuropsychologia.2018.01.042. Epub 2018 Feb 2. Review.

PMID:
29410070
7.

Management of Depression in Parkinson's Disease: A Systematic Review.

Starkstein SE, Brockman S.

Mov Disord Clin Pract. 2017 Jun 1;4(4):470-477. doi: 10.1002/mdc3.12507. eCollection 2017 Jul-Aug. Review.

8.

Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis.

Whitworth SR, Bruce DG, Starkstein SE, Davis WA, Davis TME, Skinner TC, Bucks RS.

Diabet Med. 2017 Aug;34(8):1108-1115. doi: 10.1111/dme.13372. Epub 2017 May 16.

PMID:
28453875
9.

The Structured Interview for Insight and Judgment in Dementia: Development and validation of a new instrument to assess awareness in patients with dementia.

Parrao T, Brockman S, Bucks RS, Bruce DG, Davis WA, Hatch KK, Leavy TL, Axten CA, Starkstein SE.

Alzheimers Dement (Amst). 2016 Dec 26;7:24-32. doi: 10.1016/j.dadm.2016.12.012. eCollection 2017.

10.

Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: The Fremantle Diabetes Study Phase II.

Whitworth SR, Bruce DG, Starkstein SE, Davis WA, Davis TM, Bucks RS.

Diabetes Res Clin Pract. 2016 Dec;122:190-197. doi: 10.1016/j.diabres.2016.10.023. Epub 2016 Nov 9.

PMID:
27865961
11.

Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I.

Davis WA, Zilkens RR, Starkstein SE, Davis TM, Bruce DG.

Diabetologia. 2017 Jan;60(1):89-97. Epub 2016 Oct 7.

12.

Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

Bruce DG, Davis WA, Dragovic M, Davis TM, Starkstein SE.

Depress Anxiety. 2016 Oct;33(10):960-966. doi: 10.1002/da.22523. Epub 2016 May 10.

PMID:
27164424
13.

A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy.

Starkstein SE, Brockman S, Hatch KK, Bruce DG, Almeida OP, Davis WA, Robinson RG.

J Stroke Cerebrovasc Dis. 2016 May;25(5):1119-1127. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.032. Epub 2016 Feb 22.

PMID:
26915605
14.

Modeling anxiety in Parkinson's disease.

Broen MP, Köhler S, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF.

Mov Disord. 2016 Mar;31(3):310-6. doi: 10.1002/mds.26461. Epub 2015 Dec 21.

PMID:
26685935
15.

Lifetime depression history and depression risk in type 2 diabetes: A case-control study.

Bruce DG, Davis WA, Hunter ML, Peters KE, Davis TM, Starkstein SE.

J Diabetes Complications. 2016 Jan-Feb;30(1):38-42. doi: 10.1016/j.jdiacomp.2015.10.010. Epub 2015 Oct 21.

PMID:
26604164
16.

The 'Preliminary Discourse' to Methodical Nosology, by François Boissier de Sauvages (1772).

Starkstein SE, Berrios GE.

Hist Psychiatry. 2015 Dec;26(4):477-91. doi: 10.1177/0957154X15602361.

PMID:
26574063
17.

Drowning hazard with deep brain stimulation: case report.

Bangash OK, Thorburn M, Garcia-Vega J, Walters S, Stell R, Starkstein SE, Lind CR.

J Neurosurg. 2016 May;124(5):1513-6. doi: 10.3171/2015.5.JNS15589. Epub 2015 Nov 13.

PMID:
26566200
18.

The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes Study.

Davis WA, Starkstein SE, Bruce DG, Davis TM.

J Diabetes Complications. 2015 Nov-Dec;29(8):1320-2. doi: 10.1016/j.jdiacomp.2015.08.019. Epub 2015 Aug 28.

PMID:
26387807
19.

Risk of suicide in Australian adults with diabetes: the Fremantle Diabetes Study.

Davis WA, Starkstein SE, Bruce DG, Davis TM.

Intern Med J. 2015 Sep;45(9):976-80. doi: 10.1111/imj.12853.

PMID:
26332624
20.

Is the Parkinson Anxiety Scale comparable across raters?

Forjaz MJ, Ayala A, Martinez-Martin P, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Leentjens AF.

Mov Disord. 2015 Apr;30(4):545-51. doi: 10.1002/mds.26111. Epub 2014 Dec 27.

PMID:
25546697
21.

Factor analysis of the Hamilton Depression Rating Scale in Parkinson's disease.

Broen MP, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF.

Parkinsonism Relat Disord. 2015 Feb;21(2):142-6. doi: 10.1016/j.parkreldis.2014.11.016. Epub 2014 Nov 29.

PMID:
25523963
22.

Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates.

Starkstein SE.

Cortex. 2014 Dec;61:64-73. doi: 10.1016/j.cortex.2014.07.019. Review.

PMID:
25481465
23.

Apathy in older patients with type 2 diabetes.

Bruce DG, Nelson ME, Mace JL, Davis WA, Davis TM, Starkstein SE.

Am J Geriatr Psychiatry. 2015 Jun;23(6):615-21. doi: 10.1016/j.jagp.2014.09.010. Epub 2014 Oct 2.

24.

Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.

Starkstein SE, Davis WA, Dragovic M, Cetrullo V, Davis TM, Bruce DG.

PLoS One. 2014 Nov 12;9(11):e112049. doi: 10.1371/journal.pone.0112049. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122324.

25.

The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.

Leentjens AF, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Martinez-Martin P.

Mov Disord. 2014 Jul;29(8):1035-43. doi: 10.1002/mds.25919. Epub 2014 May 23.

26.

Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.

Bruce DG, Davis WA, Starkstein SE, Davis TM.

J Alzheimers Dis. 2014;42 Suppl 3:S63-70. doi: 10.3233/JAD-132654.

PMID:
24840567
27.

Apathy following traumatic brain injury.

Starkstein SE, Pahissa J.

Psychiatr Clin North Am. 2014 Mar;37(1):103-12. doi: 10.1016/j.psc.2013.10.002. Epub 2014 Jan 10. Review.

PMID:
24529426
28.

Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase II.

Bruce DG, Davis WA, Cetrullo V, Starkstein SE, Davis TM.

PLoS One. 2013 Dec 4;8(12):e81254. doi: 10.1371/journal.pone.0081254. eCollection 2013.

29.

Imaging apathy in Alzheimer's disease.

Starkstein SE.

Int Psychogeriatr. 2014 Feb;26(2):193. doi: 10.1017/S1041610213002214. Epub 2013 Dec 2. No abstract available.

PMID:
24290158
30.

Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach.

Starkstein SE, Dragovic M, Dujardin K, Marsh L, Martinez-Martin P, Pontone GM, Richard IH, Weintraub D, Leentjens AF.

Am J Geriatr Psychiatry. 2014 Dec;22(12):1410-7. doi: 10.1016/j.jagp.2013.09.006. Epub 2013 Nov 5.

PMID:
24200594
31.

Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors.

Leentjens AF, Moonen AJ, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Köhler S.

Neurology. 2013 Sep 17;81(12):1036-43. doi: 10.1212/WNL.0b013e3182a4a503. Epub 2013 Aug 14.

32.

Rasch analysis of anxiety scales in Parkinson's disease.

Forjaz MJ, Martinez-Martin P, Dujardin K, Marsh L, Richard IH, Starkstein SE, Leentjens AF.

J Psychosom Res. 2013 May;74(5):414-9. doi: 10.1016/j.jpsychores.2013.02.009. Epub 2013 Mar 19.

PMID:
23597329
33.

Psychiatric syndromes in Parkinson's disease.

Starkstein SE, Brockman S, Hayhow BD.

Curr Opin Psychiatry. 2012 Nov;25(6):468-72. doi: 10.1097/YCO.0b013e3283577ed1. Review.

34.

Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.

Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE.

Parkinsonism Relat Disord. 2012 Dec;18(10):1084-8. doi: 10.1016/j.parkreldis.2012.06.007. Epub 2012 Jul 6.

PMID:
22771284
35.

Neurological and psychiatric aspects of emotion.

Starkstein SE, Tranel D.

Handb Clin Neurol. 2012;106:53-74. doi: 10.1016/B978-0-444-52002-9.00004-8. Review.

PMID:
22608615
36.

Apathy in Parkinson's disease: diagnostic and etiological dilemmas.

Starkstein SE.

Mov Disord. 2012 Feb;27(2):174-8. doi: 10.1002/mds.24061. Epub 2012 Jan 11.

PMID:
22237755
37.

The riddle of psychiatric disorders in Parkinson disease: from phenomenology to treatment.

Starkstein SE.

Am J Geriatr Psychiatry. 2012 Feb;20(2):99-103. doi: 10.1097/JGP.0b013e318240f90a. No abstract available.

PMID:
22172999
38.

Diagnostic criteria for depression in Alzheimer disease: a study of symptom patterns using latent class analysis.

Starkstein SE, Dragovic M, Jorge R, Brockman S, Robinson RG.

Am J Geriatr Psychiatry. 2011 Jun;19(6):551-8. doi: 10.1097/JGP.0b013e3181ec897f.

PMID:
21606898
39.

Clinicopathological correlates of behavioral and psychological symptoms of dementia.

Casanova MF, Starkstein SE, Jellinger KA.

Acta Neuropathol. 2011 Aug;122(2):117-35. doi: 10.1007/s00401-011-0821-3. Epub 2011 Apr 1. Review.

PMID:
21455688
40.

Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.

Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P.

Mov Disord. 2011 Feb 15;26(3):407-15. doi: 10.1002/mds.23184. Epub 2011 Mar 7.

PMID:
21384425
41.

Apathy and Parkinson's disease.

Starkstein SE, Brockman S.

Curr Treat Options Neurol. 2011 Jun;13(3):267-73. doi: 10.1007/s11940-011-0118-9.

PMID:
21360086
42.

Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.

Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE.

Mov Disord. 2011 Feb 15;26(3):484-92. doi: 10.1002/mds.23528. Epub 2011 Feb 10.

PMID:
21312281
43.

Anosognosia is a significant predictor of apathy in Alzheimer's disease.

Starkstein SE, Brockman S, Bruce D, Petracca G.

J Neuropsychiatry Clin Neurosci. 2010 Fall;22(4):378-83. doi: 10.1176/appi.neuropsych.22.4.378.

PMID:
21037121
44.

The frequency, clinical correlates, and mechanism of anosognosia after stroke.

Starkstein SE, Jorge RE, Robinson RG.

Can J Psychiatry. 2010 Jun;55(6):355-61. Review.

PMID:
20540830
45.

Apathy following stroke.

Jorge RE, Starkstein SE, Robinson RG.

Can J Psychiatry. 2010 Jun;55(6):350-4. Review.

PMID:
20540829
46.

Anticholinergic activity and cognitive decline in Parkinson's disease.

Starkstein SE.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):129. doi: 10.1136/jnnp.2009.194548. No abstract available.

PMID:
20145024
47.

Neuroimaging correlates of apathy and depression in Alzheimer's disease.

Starkstein SE, Mizrahi R, Capizzano AA, Acion L, Brockman S, Power BD.

J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):259-65. doi: 10.1176/appi.neuropsych.21.3.259.

PMID:
19776304
48.

Neuropsychiatric disorders in early untreated Parkinson's disease.

Starkstein SE.

J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):830. doi: 10.1136/jnnp.2008.171231. No abstract available.

PMID:
19608781
49.

The syndromal validity and nosological position of apathy in Parkinson's disease.

Starkstein SE, Merello M, Jorge R, Brockman S, Bruce D, Power B.

Mov Disord. 2009 Jun 15;24(8):1211-6. doi: 10.1002/mds.22577.

PMID:
19412942
50.

Apathy predicts more severe parkinsonism in Alzheimer's disease.

Starkstein SE, Merello M, Brockman S, Bruce D, Petracca G, Power BD.

Am J Geriatr Psychiatry. 2009 Apr;17(4):291-8.

PMID:
19322935

Supplemental Content

Loading ...
Support Center